title: Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
authors.forename: Laure A
authors.initials: LA
authors.lastname: Moutouh-de Parseval
authors.forename: Lilia
authors.initials: L
authors.lastname: Weiss
authors.forename: Robert J
authors.initials: RJ
authors.lastname: DeLap
authors.forename: Robert D
authors.initials: RD
authors.lastname: Knight
authors.forename: Jerome B
authors.initials: JB
authors.lastname: Zeldis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide